Distinct Clinical Factors in Hospitalized Patients with Diverticular Bleeding and Diverticulitis

Digestion. 2019;99(3):239-246. doi: 10.1159/000491875. Epub 2018 Sep 14.

Abstract

Background/aims: It is unclear why colonic diverticular bleeding and diverticulitis rarely coexist. This study compared the characteristics of these conditions.

Methods: This single-center retrospective study examined 310 consecutive patients hospitalized with an episode of diverticular disease (cases) and outpatients without a diverticular episode (controls) from January 2012 to December 2015. We investigated distinct clinical factors in hospitalized patients with diverticular bleeding and diverticulitis.

Results: We identified 183 patients with 263 episodes of diverticular bleeding and 127 patients with 135 episodes of diverticulitis during the study period. Patients with diverticular bleeding were significantly older than those with diverticulitis (median age 76 vs. 56 years) and had more cardiovascular disease, hypertension, diabetes, cerebrovascular disease, chronic kidney disease, lipid disorder, or a poorer performance status. Significantly more diverticular bleeding patients were taking antiplatelet drugs, anticoagulant drugs, proton pump inhibitors, or laxative agents. Multivariate analysis revealed that an age > 65 years (OR 5.42), and antiplatelet agent use (OR 7.29) were more significant risk factors for diverticular bleeding than for diverticulitis.

Conclusions: Elderly people using antiplatelet drugs may be more susceptible to diverticular bleeding than diverticulitis.

Keywords: Anticoagulant; Antiplatelet; Diverticular bleeding; Diverticulitis; Elderly people.

MeSH terms

  • Adult
  • Age Factors
  • Aged
  • Aged, 80 and over
  • Diverticulitis, Colonic / epidemiology*
  • Diverticulitis, Colonic / etiology
  • Diverticulitis, Colonic / therapy
  • Diverticulum / complications*
  • Diverticulum / therapy
  • Female
  • Gastrointestinal Hemorrhage / epidemiology*
  • Gastrointestinal Hemorrhage / etiology
  • Gastrointestinal Hemorrhage / therapy
  • Humans
  • Japan / epidemiology
  • Male
  • Middle Aged
  • Platelet Aggregation Inhibitors / adverse effects*
  • Prevalence
  • Retrospective Studies
  • Risk Factors
  • Young Adult

Substances

  • Platelet Aggregation Inhibitors